PPT-Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The

  Boris Winterhoff MD MS 11112 Stefan Kommoss MD 2 Florian Heitz MD 3 Gottfried E Konecny MD 4   Sean C Dowdy MD 5 Sally A Mullany MD 1  TjoungWon ParkSimon MD. Quang Truong. 02-13-13. Mr. . Kashub. . 2. nd. Session. What is Ovarian Cancer?. Ovarian cancer is a cancerous growth arising from the ovary. .. The “silent killer”. . What are the types of ovarian cancer you may have?. ovarian cancer patients. Laura Shawver, PhD. Founder. Applications of genomic profiling for real time decisions in cancer treatment . Overview. Ovarian Cancer statistics and treatment. Clearity. Foundation: mission and process. Advanced Malignancies. METHODS. DISCUSSION. RESULTS. . ACKNOWLEGEMENTS. . BACKGROUND. Current approaches in the treatment of advanced cancer are based predominantly upon lessons learned from the cytotoxic era. Our current approaches have yielded incremental steps forward, but most patients who develop metastatic disease still die and the costs of care are . Lisa McCluskey, MD. Gynecologic Oncologist. June 16, 2015. Compass Oncology . in partnership with . Ovarian . Cancer Alliance of Oregon & SW . Washington. What. is Ovarian Cancer. ?. The most common type of Ovarian Cancer that starts from . Diagnostic work-up. Treatment. The most commonly occurring gynecologic cancer is:. Cervical. Endometrial. Ovarian. Vulvar. The gynecologic cancer with the highest death rate is:. Cervical. Endometrial. Improvement in 5 Year Survival:. Race. 1975. 1989. 2014. All. 36%. 38%. 47%. White. 35%. 38%. 48%. African American. 42%. 34%. 39%. Noone. AM, . Howlader. N, . Krapcho. M, et al. (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute, Bethesda, MD, www.seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.. Lisa McCluskey, MD. Gynecologic Oncologist. June 16, 2015. Compass Oncology . in partnership with . Ovarian . Cancer Alliance of Oregon & SW . Washington. What. is Ovarian Cancer. ?. The most common type of Ovarian Cancer that starts from . th. most incident and lethal cancer. New cases: 225,000 annually. Deaths: 140,000 annually. *Almost 75% of cases present with advanced stage .. *Risk of relapse of advanced stage disease is as high as 70%. FS31 Ipage 1 January 2018Cancer Molecular Pro31ling No 31 in a series providing the latest information for patients caregivers and healthcare professionalswwwLLSorg 149 Information Specialist 80 Christopher Morse, MD. Fellow, Gynecologic oncology. UW MEDICINE. CONFIDENTIAL – DO NOT DISTRIBUTE. Overview. Introduction to ovarian cancer. Diagnosis and treatment. Surgery and chemotherapy. Surveillance. 2/22/2007 p lus/ rint/enc Page 2of 3 2/22/2007 p lus/ rint/enc The information provided should not be used during any medical emergency or for the diagnosis or treatment of any medical condilicensed p The George W. Morley Professor University of Michigan What is gynecologic cancer? begin in the female reproductive organs. The most common gynecologic cancers are endometrial cancer, ovarian cancer an 1 The Facts Ovarian cancer is the fourth most common cancer in women. Each year about 400 women are diagnosed with ovarian cancer in Ireland. The symptoms can be very vague, particularly when the d reproductive organs: cervical, ovarian, uterine, vaginal, and vulvar. As a group, they are referred to as gynecologic (GY-neh-kuh-LAH-jik) cancer. (A sixth type of gynecologic cancer is the very rare